BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 16253845)

  • 41. Botox for the eyes and eyebrows.
    Klein AW
    Dermatol Clin; 2004 Apr; 22(2):145-9, vi. PubMed ID: 15222574
    [TBL] [Abstract][Full Text] [Related]  

  • 42. BOTOX therapy for every dental practice.
    Malcmacher L
    Dent Today; 2009 Aug; 28(8):114, 116-7. PubMed ID: 19715075
    [No Abstract]   [Full Text] [Related]  

  • 43. Long-term prospective follow-up of botulinum toxin treatment for facial rhytides.
    Bulstrode NW; Grobbelaar AO
    Aesthetic Plast Surg; 2002; 26(5):356-9. PubMed ID: 12432474
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Botulinum toxin, immunologic considerations with long-term repeated use, with emphasis on cosmetic applications.
    Borodic G
    Facial Plast Surg Clin North Am; 2007 Feb; 15(1):11-6, v. PubMed ID: 17317551
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of the patient for cosmetic Botox injections.
    Dayan SH; Bassichis BA
    Facial Plast Surg Clin North Am; 2003 Aug; 11(3):349-58. PubMed ID: 15062263
    [No Abstract]   [Full Text] [Related]  

  • 46. BOTOX use in the mid and lower face and neck.
    Carruthers J; Carruthers A
    Semin Cutan Med Surg; 2001 Jun; 20(2):85-92. PubMed ID: 11474748
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Botulinum toxin type A: history and current cosmetic use in the upper face.
    Carruthers A; Carruthers J
    Semin Cutan Med Surg; 2001 Jun; 20(2):71-84. PubMed ID: 11474747
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Type A botulinum toxin in the upper aspect of the face.
    Hexsel D; Dal'forno T
    Clin Dermatol; 2003; 21(6):488-97. PubMed ID: 14759582
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cosmetic uses of botulinum toxins for lower aspects of the face and neck.
    Lowe NJ; Yamauchi P
    Clin Dermatol; 2004; 22(1):18-22. PubMed ID: 15158540
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Management of the ageing eyebrow and forehead: an objective dose-response study with botulinum toxin.
    Levy JL; Pons F; Jouve E
    J Eur Acad Dermatol Venereol; 2006 Jul; 20(6):711-6. PubMed ID: 16836501
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Are there any drawbacks to smoothing out lines and wrinkles with Botox injections?
    Johns Hopkins Med Lett Health After 50; 2001 Mar; 13(1):8. PubMed ID: 11232481
    [No Abstract]   [Full Text] [Related]  

  • 52. [Prevention and management of locoregional complications of botulinum A toxin injections in cosmetic treatment].
    Gassia V
    Ann Dermatol Venereol; 2009 May; 136 Suppl 4():S146-51. PubMed ID: 19576482
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Treatment of hyperfunctional facial lines with botulinum toxin].
    Böni R; Kargl A; Kreyden OP; Burg G
    Praxis (Bern 1994); 2001 Aug; 90(34):1408-12. PubMed ID: 11552321
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Botulinum toxins for facial wrinkles: beyond glabellar lines.
    Dayan SH; Maas CS
    Facial Plast Surg Clin North Am; 2007 Feb; 15(1):41-9, vi. PubMed ID: 17317554
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Periocular botulinum toxin.
    Flynn TC
    Clin Dermatol; 2003; 21(6):498-504. PubMed ID: 14759583
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A new technique applying botulinum toxin in narrow and wide foreheads.
    Ozsoy Z; Genc B; Gözü A
    Aesthetic Plast Surg; 2005; 29(5):368-72. PubMed ID: 16151661
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Botulinum toxin injection techniques in the lower third and middle of the face, the neck and the décolleté: the "Nefertiti lift"].
    Gassia V; Beylot C; Béchaux S; Michaud T
    Ann Dermatol Venereol; 2009 May; 136 Suppl 4():S111-8. PubMed ID: 19576476
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Adding ancillaries. Botox injections.
    Tolkoff M
    Med Econ; 2006 Feb; 83(3):55-6. PubMed ID: 16506629
    [No Abstract]   [Full Text] [Related]  

  • 59. Botox: shaken, not stirred.
    Kazim NA; Black EH
    Ophthalmic Plast Reconstr Surg; 2008; 24(1):10-2. PubMed ID: 18209633
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cosmetic indications for botulinum A toxin.
    Foster JA; Wulc AE; Holck DE
    Semin Ophthalmol; 1998 Sep; 13(3):142-8. PubMed ID: 9787215
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.